Primary non-small cell lung cancer response upon treatment with denosumab
- PMID: 24075124
- DOI: 10.1016/j.lungcan.2013.08.030
Primary non-small cell lung cancer response upon treatment with denosumab
Abstract
Here we report the case of a patient with metastatic adenocarcinoma of the lung harboring an ALK gene translocation. In this patient a response of the primary tumor and metastases has been detected upon treatment with denosumab. A possible link between ALK and RANK is postulated.
Keywords: ALK; Crizotinib; Denosumab; NF-kB; Non small cell lung cancer; RANK; RANKL.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer.J Clin Oncol. 2012 Jun 1;30(16):e147-50. doi: 10.1200/JCO.2011.39.9766. Epub 2012 Apr 16. J Clin Oncol. 2012. PMID: 22508824 No abstract available.
-
Treatment and detection of ALK-rearranged NSCLC.Lung Cancer. 2013 Aug;81(2):145-54. doi: 10.1016/j.lungcan.2013.03.017. Epub 2013 Jun 12. Lung Cancer. 2013. PMID: 23769207 Review.
-
Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation.Lung Cancer. 2012 Aug;77(2):460-3. doi: 10.1016/j.lungcan.2012.04.012. Epub 2012 May 21. Lung Cancer. 2012. PMID: 22622260
-
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.J Clin Oncol. 2013 Jun 20;31(18):2273-81. doi: 10.1200/JCO.2012.44.5932. Epub 2013 May 13. J Clin Oncol. 2013. PMID: 23669222
-
Crizotinib: a new treatment option for ALK-positive non-small cell lung cancer.Ann Pharmacother. 2013 Feb;47(2):189-97. doi: 10.1345/aph.1R002. Epub 2013 Feb 5. Ann Pharmacother. 2013. PMID: 23386065 Review.
Cited by
-
A Review of Monoclonal Antibody-Based Treatments in Non-small Cell Lung Cancer.Adv Exp Med Biol. 2021;1286:49-64. doi: 10.1007/978-3-030-55035-6_3. Adv Exp Med Biol. 2021. PMID: 33725344 Review.
-
Snail1-expressing cancer-associated fibroblasts induce lung cancer cell epithelial-mesenchymal transition through miR-33b.Oncotarget. 2017 Dec 7;8(70):114769-114786. doi: 10.18632/oncotarget.23082. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383119 Free PMC article.
-
The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.Onco Targets Ther. 2017 Jul 27;10:3801-3810. doi: 10.2147/OTT.S135867. eCollection 2017. Onco Targets Ther. 2017. PMID: 28794644 Free PMC article. Review.
-
The road of NSCLC stem cells toward bone metastases.Bone Rep. 2022 Sep 5;17:101619. doi: 10.1016/j.bonr.2022.101619. eCollection 2022 Dec. Bone Rep. 2022. PMID: 36110341 Free PMC article.
-
Effects of RANKL-Targeted Therapy in Immunity and Cancer.Front Oncol. 2014 Jan 7;3:329. doi: 10.3389/fonc.2013.00329. eCollection 2014 Jan 7. Front Oncol. 2014. PMID: 24432249 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical